Cellular mechanisms of alveolar pathology in childhood interstitial lung diseases: Current insights from mouse genetics

Current Opinion in Pediatrics

Volumn 27, Issue 3, 2015, Pages 341-347

  Kuo, Christin S ^a   Desai, Tushar J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

alveolar epithelial type II cell; childhood interstitial lung disease; surfactant

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A3; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; UNCLASSIFIED DRUG;

CHILDHOOD DISEASE; GENE MUTATION; GENETICS; GENOMICS; HUMAN; IN VIVO STUDY; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STEM CELL; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CHILD; CYTOLOGY; DISEASE MODEL; LUNG; MOUSE; NUCLEAR REPROGRAMMING; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CELLULAR REPROGRAMMING; CHILD; DISEASE MODELS, ANIMAL; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; MICE; PULMONARY ALVEOLI; SIGNAL TRANSDUCTION;

EID: 84939654887     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0000000000000227     Document Type: Review

References (45)

1. Deutsch GH, Young LR, Deterding RR, et al. Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med 2007; 176:1120-1128.
2. Soares JJ, Deutsch GH, Moore PE, et al. Childhood interstitial lung diseases: an 18-year retrospective analysis. Pediatrics 2013; 132:684-691.
3. Shulenin S, Nogee LM, Annilo T, et al. ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med 2004; 350:1296-1303.
4. Nogee LM, Garnier G, Dietz HC, et al. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 1994; 93:1860-1863.
5. Nogee LM, Dunbar AE3, Wert SE, et al. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001; 344:573-579.
6. Wert SE, Whitsett JA, Nogee LM. Genetic disorders of surfactant dysfunction. Pediatr Dev Pathol 2009; 12:253-274.
7. Kurland G, Deterding RR, Hagood JS, et al. An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med 2013; 188:376-394.
8. Streets AM, Zhang X, Cao C, et al. Microfluidic single-cell whole-transcrip-tome sequencing. Proc Natl Acad Sci 2014; 111:7048-7053.
9. Kretzschmar K, Watt FM. Lineage tracing. Cell Elsevier Inc 2012; 148:33-45.
10. Gierut JJ, Jacks TE, Haigis KM. Strategies to achieve conditional gene mutation in mice. Cold Spring Harbor Protocols 2014; 2014:339-349. doi: 10.1101/pdb.top069807.
11. Morrisey EE, Hogan BLM. Preparing for the first breath: genetic and cellular mechanisms in lung development. Dev Cell 2010; 18:8-23.
12. Kotton DN, Morrisey EE. Lung regeneration: mechanisms, applications and emerging stem cell populations. Nat Med 2014; 20:822-832.
13. Whitsett JA, Wert SE, Weaver TE. Diseases of pulmonary surfactant home-ostasis. Annu Rev Pathol Mech Dis 2015; 10:371-393.
14. Desai TJ, Brownfield DG, Krasnow MA. Alveolar progenitor and stem cells in lung development, renewal and cancer. Nature 2014; 507:190-194.
15. Treutlein B, Brownfield DG, Wu AR, et al. Reconstructing lineage hierarchies of the distal lung epithelium using single-cell RNA-seq. Nature 2014; 509: 1-16.
16. Barkauskas CE, Cronce MJ, Rackley CR, et al. Type 2 alveolar cells are stem cells in adult lung. J Clin Invest 2013; 123:3025-3036.
17. Vaughan AE, Brumwell AN, Xi Y, et al. Lineage-negative progenitors mobilize to regenerate lung epithelium after major injury. Nature 2015; 517:621-625.
18. Zuo W, Zhang T, Wu DZ, et al. distal airway stem cells are essential for lung regeneration. Nature 2015; 517:616-620.
19. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. 2002. pp. 277-304.
20. Uhal BD, Joshi I, Hughes WF, et al. Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am J Physiol 1998; 275 (6 Pt 1):L1192-L1199.
21. Sisson TH, Mendez M, Choi K, et al. Targeted injury of type II alveolar epithelial cells induces pulmonaryfibrosis. Am J Respir Crit Care Med 2010; 181:254-263.
22. Mulugeta S. Identification of LBM180, a lamellar body limiting membrane protein of alveolar type II cells, as the ABC transporter protein ABCA3. J Biol Chem 2002; 277:22147-22155.
23. Whitsett JA, Weaver TE. Hydrophobic surfactant proteins in lung function and disease. N Engl J Med 2002; 347:2141-2148.
24. Nogee LM, de Mello DE, Dehner LP, Colten HR. Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med 1993; 328:406-410.
25. Tredano M, van Elburg RM, Kaspers AG, et al. Compound SFTPB 1549C->GAA (121ins2) and 457delC heterozygosity in severe congenital lung disease and surfactant protein B (SP-B) deficiency. Hum Mutat 1999; 14:502-509.
26. Cutz E, Wert SE, Nogee LM, Moore AM. Deficiency of lamellar bodies in alveolar type II cells associated with fatal respiratory disease in a full-term infant. Am J Respir Crit Care Med 2000; 161 (2 Pt 1):608-614.
27. Wallot M, Wagenvoort C, deMello D, et al. Congenital alveolar proteinosis caused by a novel mutation of the surfactant protein B gene and misalignment of lung vessels in consanguineous kindred infants. Eur J Pediatr 1999; 158:513-518.
28. Katzenstein AL, Gordon LP, Oliphant M, Swender PT. Chronic pneumonitis of infancy. A unique form of interstitial lung disease occurring in early childhood. Am J Surg Pathol 1995; 19:439-447.
29. Dishop MK. Paediatric respiratory reviews. Paediatr Respir Rev 2011; 12:230-237.
30. Thomas AQ, Lane K, Phillips J 3rd, et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 2002; 165:1322-1328.
31. van Moorsel CH, van Oosterhout MF, Barlo NP, et al. Surfactant protein C mutations are the basisofa significant portion of adult familial pulmonary fibrosis in a Dutch cohort. Am J Respir Crit Care Med 2010; 182:1419-1425.
32. Buckingham S, Avery ME. Time of appearance of lung surfactant in the foetal mouse. Nature 1962; 193:688-689.
33. Buckingham S, McNary WF, Sommers SC. Pulmonary alveolar cell inclusions: Their development in the rat. Science 1964; 145:1192-1193.
34. Sirianni FE, Chu FSF, Walker DC. Human alveolar wall fibroblasts directly link epithelial type 2 cells to capillary endothelium. Am J Respir Crit Care Med 2003; 168:1532-1537.
35. Adamson IY, Hedgecock C, Bowden DH. Epithelial cell-fibroblast interactions in lung injury and repair. Am J Pathol 1990; 137:385-392.
36. Chen L, Acciani T, Le Cras T, et al. Dynamic regulation of platelet-derived growth factor receptor a expression in alveolar fibroblasts during realveolar-ization. Am J Respir Cell Mol Biol 2012; 47:517-527.
37. Glasser SW, Burhans MS, Korfhagen TR, et al. Altered stability of pulmonary surfactant in SP-C-deficient mice. Proc Natl Acad Sci USA 2001; 98:6366-6371.
38. Clark JC, Wert SE, Bachurski CJ, et al. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci USA 1995; 92:7794-7798.
39. Ban N, Matsumura Y, Sakai H, et al. ABCA3as a lipid transporter in pulmonary surfactant biogenesis. J Biol Chem 2007; 282:9628-9634.
40. Cheong N, Zhang H, Madesh M, et al. ABCA3 is critical for lamellar body biogenesis in vivo. J Biol Chem 2007; 282:23811-23817.
41. Hammel M, Michel G, Hoefer C, et al. Targeted inactivation of the murine Abca3 gene leads to respiratory failure in newborns with defective lamellar bodies. Biochem Biophys Res Comm 2007; 359:947-951.
42. Mulugeta S, Nguyen V, Russo SJ, et al. A Surfactant Protein C Precursor Protein BRICHOS domain mutation causes endoplasmic reticulum stress, proteasome dysfunction, and caspase 3 activation. Am J Respir Cell Mol Biol 2005; 32:521-530.
43. Wang WJ, Mulugeta S, Russo SJ, Beers MF. Deletion of exon 4 from human surfactant protein C results in aggresome formation and generation of a dominant negative. J Cell Sci 2003; 116 (Pt 4):683-692.
44. Bridges JP, Wert SE, Nogee LM, Weaver TE. Expressionof a human surfactant protein C mutation associated with interstitial lung disease disrupts lung development in transgenic mice. J Biol Chem 2003; 278:52739-52746.
45. Flamein F, Riffault L, Muselet-Charlier C, et al. Molecular and cellular char acteristics of ABCA3 mutations associated with diffuse parenchymal lung diseases in children. Hum Mol Genet 2012; 21:765-775.